|
1
|
Yamani M, Obaid EF and Hemida AH: Moyamoya
syndrome in a 32-year-old male with sickle cell anemia. Cureus.
12(e10001)2020.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Al-Hawsawi ZM, Al-Zaid MA, Barnawi AI and
Yassine SM: Fanconi anemia associated with moyamoya disease in
Saudi Arabia. Saudi Med J. 36:233–235. 2015.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Meena SS, Ramkumar TV, Sharma S, Aneja S
and Kumar A: Moyamoya syndrome associated with severe iron
deficiency anemia in a young child. Pediatr Hematol Oncol.
29:368–371. 2012.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Das S, Dubey S, Acharya M, Chatterjee S,
Lahiri D, Das G, Ray BK and Kraemer M: Thalassemia and moyamoya
syndrome: Unfurling an intriguing association. J Neurol.
266:2838–2847. 2019.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Bersano A, Guey S, Bedini G, Nava S, Hervé
D, Vajkoczy P, Tatlisumak T, Sareela M, van der Zwan A, Klijn CJ,
et al: Research progresses in understanding the pathophysiology of
moyamoya disease. Cerebrovasc Dis. 41:105–118. 2016.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Zhang L, Xing W and Zhang J: Recurrent
transient ischemic attacks in a moyamoya syndrome patient with
ultra-long imaging follow-up. Quant Imaging Med Surg. 12:2144–2152.
2022.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Liu XJ, Zhang D, Wang S, Zhao YL, Teo M,
Wang R, Cao Y, Ye X, Kang S and Zhao JZ: Clinical features and
long-term outcomes of moyamoya disease: A single-center experience
with 528 cases in China. J Neurosurg. 122:392–399. 2015.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Shindo T, Ito M, Sugiyama T, Okuyama T,
Kono M, Atsumi T and Fujimura M: Diagnostic value of vessel wall
imaging to determine the timing of extracranial-intracranial bypass
for moyamoya syndrome associated with active Sjögren's syndrome: A
case report. J Neurol Surg A Cent Eur Neurosurg: Apr 22, 2022 (Epub
ahead of print). doi: 10.1055/a-1832-3269.
|
|
9
|
Santoro JD, Lee S, Wang AC, Ho E, Nagesh
D, Khoshnood M, Tanna R, Durazo-Arvizu RA, Manning MA, Skotko BG,
et al: Increased autoimmunity in individuals with down syndrome and
moyamoya disease. Front Neurol. 12(724969)2021.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Nagel MA, Niemeyer CS and Bubak AN:
Central nervous system infections produced by varicella zoster
virus. Curr Opin Infect Dis. 33:273–278. 2020.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Salih MA, Murshid WR, Al-Salman MM,
Abdel-Gader AG, Al-Jarallah AA, Alorainy IA, Hassan HH, Kentab AY,
Van Maldergem L, Othman SA, et al: Moyamoya syndrome as a risk
factor for stroke in Saudi children. Novel and usual associations.
Saudi Med J. 27 (Suppl 1):S69–S80. 2006.PubMed/NCBI
|
|
12
|
Piel FB and Weatherall DJ: The
α-thalassemias. N Engl J Med. 371:1908–1916. 2014.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Modell B and Darlison M: Global
epidemiology of haemoglobin disorders and derived service
indicators. Bull World Health Organ. 86:480–487. 2008.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Chui DH: Alpha-thalassaemia and population
health in Southeast Asia. Ann Hum Biol. 32:123–130. 2005.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Shang X, Peng Z, Ye Y, Asan Zhang X, Chen
Y, Zhu B, Cai W, Chen S, Cai R, et al: Rapid targeted
next-generation sequencing platform for molecular screening and
clinical genotyping in subjects with hemoglobinopathies.
EBioMedicin. 23:150–159. 2017.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Berry JA, Cortez V, Toor H, Saini H and
Siddiqi J: Moyamoya: An update and review. Cureus.
12(e10994)2020.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Newman S, Boulter JH, Malcolm JG, Pradilla
I and Pradilla G: Outcomes in patients with moyamoya syndrome and
sickle cell disease: A systematic review. World Neurosurg.
135:165–170. 2020.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Zhang H, Zheng L and Feng L: Epidemiology,
diagnosis and treatment of moyamoya disease. Exp Ther Med.
17:1977–1984. 2019.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Wu H, Huang Q, Yu Z and Zhong Z: Molecular
analysis of alpha- and beta-thalassemia in Meizhou region and
comparison of gene mutation spectrum with different regions of
Southern China. J Clin Lab Anal. 35(e24105)2021.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Huang Y, Long Y, Deng D, Liu Z, Liang H,
Sun N, Xu Y, Lai Y and Cheng P: Alterations of anticoagulant
proteins and soluble endothelial protein C receptor in thalassemia
patients of Chinese origin. Thromb Res. 172:61–66. 2018.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Gallagher PG: Disorders of erythrocyte
hydration. Blood. 130:2699–2708. 2017.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Litvinov RI and Weisel JW: Role of red
blood cells in haemostasis and thrombosis. ISBT Sci Ser.
12:176–183. 2017.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Bhattacharyya M, Kannan M, Chaudhry VP,
Mahapatra M, Pati H and Saxena R: Hypercoagulable state in five
thalassemia intermedia patients. Clin Appl Thromb Hemost.
13:422–427. 2007.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Doctor PN, Choudhari A, Verma M and
Merchant RH: Moyamoya syndrome in hemoglobin E-beta thalassemia: A
rare presentation and association. J Postgrad Med. 64:240–242.
2018.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Zahra A, Al-Abboh H, Habeeb Y and Adekile
A: Moyamoya syndrome in a child with HbEβ-thalassemia. Clin Case
Rep. 10(e05536)2022.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Jang DK, Lee KS, Rha HK, Huh PW, Yang JH,
Park IS, Ahn JG, Sung JH and Han YM: Bypass surgery versus medical
treatment for symptomatic moyamoya disease in adults. J Neurosurg.
127:492–502. 2017.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Zhao X, Wang X, Wang M, Meng Q and Wang C:
Treatment strategies of ruptured intracranial aneurysms associated
with moyamoya disease. Brit J Neurosurg. 35:209–215.
2021.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Kuroda S and Houkin K: Bypass surgery for
moyamoya disease: Concept and essence of sugical techniques. Neurol
Med Chir (Tokyo). 52:287–294. 2012.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Ren B, Zhang ZS, Liu WW, Bao XY, Li DS,
Han C, Xian P, Zhao F, Wang H, Wang H and Duan L: Surgical outcomes
following encephaloduroarteriosynangiosis in adult moyamoya disease
associated with type 2 diabetes. J Neurosurg. 125:308–314.
2016.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Miyamoto S, Yoshimoto T, Hashimoto N,
Okada Y, Tsuji I, Tominaga T, Nakagawara J and Takahashi JC: JAM
Trial Investigators. Effects of extracranial-intracranial bypass
for patients with hemorrhagic moyamoya disease: Results of the
Japan adult moyamoya trial. Stroke. 45:1415–1421. 2014.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Wan M and Duan L: Recent progress in
hemorrhagic moyamoya disease. Br J Neurosurg. 29:189–191.
2015.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Han Q, Yao F, Zhang Z and Huang Y:
Evaluation of revascularization in different Suzuki stages of
ischemic moyamoya disease by whole-brain CT perfusion. Front
Neurol. 12(683224)2021.PubMed/NCBI View Article : Google Scholar
|
